Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
-
Zosuquidar (LY335979) 3HCl: Potent P-gp Inhibitor for Can...
2025-12-06
Zosuquidar (LY335979) 3HCl is a highly selective P-glycoprotein (P-gp) inhibitor shown to reverse multidrug resistance (MDR) in cancer. Its competitive mechanism restores chemotherapeutic drug efficacy in vitro and in vivo. APExBIO’s Zosuquidar provides a standard tool for experimental and translational studies targeting P-gp mediated drug resistance.
-
Zosuquidar (LY335979) 3HCl: P-gp Inhibitor for Chemothera...
2025-12-05
Zosuquidar (LY335979) 3HCl is a highly selective P-glycoprotein modulator that restores chemotherapy sensitivity in multidrug-resistant cancer cells. This article presents atomic, verifiable facts on its mechanism of action, benchmarks, and practical integration in oncology workflows.
-
Zosuquidar (LY335979): P-gp Inhibitor for Multidrug Resis...
2025-12-04
Zosuquidar (LY335979) 3HCl is a next-generation P-glycoprotein modulator that empowers researchers to directly reverse multidrug resistance in cancer cells. This guide details applied workflows, advanced use-cases, and troubleshooting strategies for maximizing drug sensitization in challenging oncology models.
-
Zosuquidar (LY335979): Precision P-gp Inhibitor for MDR R...
2025-12-03
Zosuquidar (LY335979) 3HCl from APExBIO enables reliable, potent reversal of multidrug resistance (MDR) in cancer by targeting the P-glycoprotein efflux pump. This guide details hands-on workflows, data-driven troubleshooting, and translational applications for maximizing chemotherapy sensitization and experimental reproducibility.
-
G418 Sulfate (Geneticin, G-418): Reliable Selection and A...
2025-12-02
This article delivers an evidence-based, scenario-driven guide to deploying G418 Sulfate (Geneticin, G-418) (SKU A2513) for robust cell selection and antiviral assays. Addressing real-world laboratory challenges, it integrates experimental design, protocol optimization, and product reliability, empowering researchers to achieve reproducible, high-fidelity results in genetic engineering and virology workflows.
-
Kanamycin Sulfate: Aminoglycoside Antibiotic for Cell Cul...
2025-12-01
Kanamycin Sulfate stands out as a water-soluble aminoglycoside antibiotic, empowering precise cell culture selection and robust antibiotic resistance research. Its unique mechanism and high purity make it indispensable for advanced microbiology and molecular biology workflows, surpassing conventional antibiotics in both reliability and scope.
-
Beyond Selection: G418 Sulfate (Geneticin, G-418) as a Pr...
2025-11-30
G418 Sulfate (Geneticin, G-418) has long been a cornerstone of genetic engineering and cell culture selection. However, the field is rapidly advancing, and translational researchers now demand more than routine selection—they seek mechanistic insight, strategic precision, and tools that enable robust experimentation across disciplines. This article explores the multifaceted utility of G418 Sulfate, integrating new evidence from synthetic lethality paradigms in cancer research and emerging antiviral applications. We chart the molecule’s mechanism, experimental validation, and competitive landscape, offering strategic guidance for leveraging its unique properties to accelerate translational breakthroughs.
-
G418 Sulfate (Geneticin, G-418): Selective Agent for Gene...
2025-11-29
G418 Sulfate (Geneticin, G-418) is a high-purity aminoglycoside antibiotic used as a selective agent for cells expressing the neomycin resistance gene. Its robust inhibition of protein synthesis via the 80S ribosome supports reproducible genetic engineering and antiviral studies. APExBIO’s G418 Sulfate (A2513) delivers validated, benchmarked performance for stable cell line generation and Dengue virus inhibition.
-
G418 Sulfate (Geneticin, G-418): Mechanism, Evidence, and...
2025-11-28
G418 Sulfate (Geneticin, G-418) is a highly effective aminoglycoside antibiotic used as a selective agent for neomycin resistance gene expression and as a protein synthesis inhibitor targeting the 80S ribosome. Its robust performance in genetic engineering and antiviral workflows is supported by extensive research and quantitative benchmarks. This article clarifies its mechanism, evidence, and practical boundaries for scientific use.
-
Zosuquidar (LY335979): Advanced P-gp Inhibition for Rever...
2025-11-27
Zosuquidar (LY335979) 3HCl unlocks new capabilities in overcoming multidrug resistance (MDR) in cancer by precisely targeting P-glycoprotein (P-gp) efflux pumps. This guide delivers actionable experimental workflows, troubleshooting strategies, and expert insights for researchers seeking to transform chemotherapy outcomes using APExBIO’s trusted P-gp inhibitor.
-
G418 Sulfate: The Gold Standard for Precise Genetic Engin...
2025-11-26
G418 Sulfate (Geneticin, G-418) from APExBIO delivers unmatched precision for cell line selection and antiviral workflows, standing out as both a protein synthesis inhibitor and a selective agent for neomycin resistance. Its dual functionality empowers robust genetic engineering and translational research, driving advancements from oncology to virology.
-
G418 Sulfate (Geneticin): Beyond Selection—A Molecular To...
2025-11-25
Explore how G418 Sulfate (Geneticin, G-418) advances research as a selective agent for the neomycin resistance gene and a protein synthesis inhibitor targeting the 80S ribosome. This in-depth analysis uniquely connects its utility to emerging calcium signaling pathways and cancer metastasis models.
-
G418 Sulfate (Geneticin, G-418): Selective Ribosome Inhib...
2025-11-24
G418 Sulfate (Geneticin, G-418) is an aminoglycoside antibiotic widely utilized as a selective agent for the neomycin resistance gene and as an inhibitor of 80S ribosomal protein synthesis. With proven efficacy in both genetic engineering and antiviral applications, it remains a gold-standard tool for precision selection in molecular biology workflows.
-
Kanamycin Sulfate (SKU A2516): Best Practices for Cell Cu...
2025-11-23
This authoritative article explores scenario-driven challenges in cell viability, proliferation, and cytotoxicity assays, offering data-backed solutions using Kanamycin Sulfate (SKU A2516). Drawing on recent literature and validated protocols, it guides biomedical researchers in optimizing antibiotic selection for reproducible, sensitive, and safe experimental workflows.
-
G418 Sulfate (Geneticin, G-418): Data-Driven Selection fo...
2025-11-22
This article explores real-world laboratory challenges and provides scenario-based, scientifically grounded guidance for using G418 Sulfate (Geneticin, G-418, SKU A2513) in cell viability, proliferation, and antiviral assays. Learn how this aminoglycoside antibiotic streamlines genetic engineering workflows, ensures robust selection, and delivers validated performance supported by quantitative data and peer-reviewed research.
16147 records 20/1077 page Previous Next First page 上5页 1617181920 下5页 Last page